🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Metastatic Sarcoma

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial NCT05333458Phase 213 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles National Cancer Institute (NCI) · Tests: Atezolizumab, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) NCT07193550Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Zanzalintinib AB122 Platform Study NCT04999761Phase 19 sites📍 Aichi📍 Chiba📍 Ehime Taiho Pharmaceutical Co., Ltd. · Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma. NCT07460986Phase 1, Phase 211 sites📍 Badalona📍 Barakaldo📍 Barcelona MedSIR · Tests: bexmarilimab, Doxorubicin Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma NCT04199026NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Doxorubicin, Doxorubicin Hydrochloride, Drug Delivery Microdevice, Everolimus, Ganitumab Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites📍 Washington D.C.📍 Baltimore📍 Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Consolidative radiation therapy (cRT) A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites📍 Los Angeles📍 Sarasota📍 St Louis Angiex, Inc. · Tests: AGX101 XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma NCT06571734Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Echocardiography, Multigated Acquisition Scan, Zanzalintinib Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse NCT07871864Phase 377 sites📍 Aarhus📍 Aarhus📍 Copenhagen Gustave Roussy, Cancer Campus, Grand Paris · Tests: Experimental group : Cabometyx ® 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (i… Musculoskeletal Cancers Remote Monitoring and Care NCT07129226NA1 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Smart Watch Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD146/HER2 CAR-T cells Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Becotatug Vedotin EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) NCT03016819Phase 324 sites📍 Phoenix📍 Los Angeles📍 Santa Monica Advenchen Laboratories, LLC · Tests: AL3818, Dacarbazine, AL3818 or placebo, Midazolam 2 mg for CYP3A4 phenotyping, Digoxin (0.25mg) Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma NCT07283731Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Zanzalintinib, Pembrolizumab A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites📍 Birmingham📍 Aurora📍 Washington D.C. Nationwide Children's Hospital · Tests: Cabozantinib Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection A Study of CRD3874-SI in People With Solid Tumors NCT06021626Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: CRD3874 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer NCT06298916Phase 1, Phase 25 sites📍 Duarte📍 Orange📍 Stanford Lantheus Medical Imaging · Tests: 64Cu-LNTH-1363S ACTengine® IMA203 Combined With mRNA-4203 NCT06946225Phase 14 sites📍 San Francisco📍 Boston📍 New York Immatics US, Inc. · Tests: IMA203, mRNA-4203 Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors NCT07630961Phase 12 sites📍 Odense C📍 Chuo Ku Novartis Pharmaceuticals · Tests: 68Ga-DFC413, 68Ga-NNS309 A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation NCT07458347Phase 19 sites📍 Los Angeles📍 Sarasota📍 Tampa Kestrel Therapeutics, Inc. · Tests: KST-6051, Gemcitabine/nab-paclitaxel, Cetuximab, Pembrolizumab, mFOLFOX6 Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma NCT06827717Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: irinotecan liposome (II) + temozolomide + fluzoparib A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg NCT04332874Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Isolated Limb Infusion, Pembrolizumab, infusion of melphalan and dactinomycin A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements NCT03093116Phase 1, Phase 2165 sites📍 Duarte📍 Glendale📍 La Jolla Turning Point Therapeutics, Inc. · Tests: Oral repotrectinib (TPX-0005) IVIM & OLINK in Sarcoma NCT05950594Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Radiotherapy, Surgery Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma NCT05235165Phase 3233 sites📍 Birmingham📍 Anchorage📍 Kingman Children's Oncology Group · Tests: Biospecimen Collection, Computed Tomography, Questionnaire Administration, Thoracoscopy, Thoracotomy Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes NCT07194044Phase 121 sites📍 Birmingham📍 Phoenix📍 Hartford H. Lee Moffitt Cancer Center and Research Institute · Tests: Vincristine, Doxorubicin, Cyclophosphamide, Ifosfamide, Actinomycin Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125Phase 11 site📍 Chicago Ann & Robert H Lurie Children's Hospital of Chicago · Tests: Cytalux
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy